An ex vivo rat trachea model reveals abnormal airway physiology and a gland secretion defect in cystic fibrosis

Cystic fibrosis (CF) is a genetic disease hallmarked by aberrant ion transport that results in delayed mucus clearance, chronic infection, and progressive lung function decline. Several animal models have been developed to study the airway anatomy and mucus physiology in CF, but they are costly and difficult to maintain, making them less accessible for many applications. A more available CFTR−/− rat model has been developed and characterized to develop CF airway abnormalities, but consistent dosing of pharmacologic agents and longitudinal evaluation remain a challenge. In this study, we report the development and characterization of a novel ex vivo trachea model that utilizes both wild type (WT) and CFTR−/− rat tracheae cultured on a porcine gelatin matrix. Here we show that the ex vivo tracheae remain viable for weeks, maintain a CF disease phenotype that can be readily quantified, and respond to stimulation of mucus and fluid secretion by cholinergic stimulation. Furthermore, we show that ex vivo tracheae may be used for well-controlled pharmacological treatments, which are difficult to perform on freshly excised trachea or in vivo models with this degree of scrutiny. With improved interrogation possible with a durable trachea, we also established firm evidence of a gland secretion defect in CFTR−/− rat tracheae compared to WT controls. Finally, we demonstrate that the ex vivo tracheae can be used to generate high mucus protein yields for subsequent studies, which are currently limited by in vivo mucus collection techniques. Overall, this study suggests that the ex vivo trachea model is an effective, easy to set up culture model to study airway and mucus physiology.

[1]  Zhuoyue Chen,et al.  Advances in the development and optimization strategies of the hemostatic biomaterials , 2023, Frontiers in Bioengineering and Biotechnology.

[2]  J. Sznitman,et al.  Exploring pulmonary distribution of intratracheally instilled liquid foams in excised porcine lungs , 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  B. Grubb,et al.  Animal models of cystic fibrosis in the era of highly effective modulator therapies. , 2022, Current opinion in pharmacology.

[4]  S. Birket,et al.  Muc5b Contributes to Mucus Abnormality in Rat Models of Cystic Fibrosis , 2022, Frontiers in Physiology.

[5]  I. Vachier,et al.  Methods of Sputum and Mucus Assessment for Muco-Obstructive Lung Diseases in 2022: Time to “Unplug” from Our Daily Routine! , 2022, Cells.

[6]  Jae Young Choi,et al.  Combined agonists act synergistically to increase mucociliary clearance in a cystic fibrosis airway model , 2021, Scientific Reports.

[7]  L. Zaragosi,et al.  Motile cilia and airway disease. , 2020, Seminars in cell & developmental biology.

[8]  M. Donnelley,et al.  Animal and Cell Culture Models for Cystic Fibrosis: Which Model is Right for Your Application? , 2020, The American journal of pathology.

[9]  G. Tearney,et al.  Ivacaftor Reverses Airway Mucus Abnormalities in a Rat Model Harboring a Humanized G551D-CFTR. , 2020, American journal of respiratory and critical care medicine.

[10]  R. Bridges,et al.  Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells , 2020, bioRxiv.

[11]  M. Donnelley,et al.  Phenotypic characterization and comparison of Phe508del and cystic fibrosis transmembrane conductance regulator (CFTR) knockout rat models of cystic fibrosis generated by CRISPR/Cas9 gene editing. , 2020, The American journal of pathology.

[12]  G. Tearney,et al.  Excess mucus viscosity and airway dehydration impact COPD airway clearance , 2019, European Respiratory Journal.

[13]  J. Hornberg,et al.  Use of precision cut lung slices as a translational model for the study of lung biology , 2019, Respiratory Research.

[14]  Gareth W. Hughes,et al.  A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus. , 2019, JCI insight.

[15]  D. Stoltz,et al.  Mucociliary Transport in Healthy and Cystic Fibrosis Pig Airways , 2018, Annals of the American Thoracic Society.

[16]  D. Thornton,et al.  Mucins: the frontline defence of the lung , 2018, Biochemical Society transactions.

[17]  Martin Donnelley,et al.  Airway disease phenotypes in animal models of cystic fibrosis , 2018, Respiratory Research.

[18]  Guillermo J Tearney,et al.  Development of an airway mucus defect in the cystic fibrosis rat. , 2018, JCI insight.

[19]  F. Jamar,et al.  Aerosol delivery during invasive mechanical ventilation: a systematic review , 2017, Critical Care.

[20]  A. Zoso,et al.  Animal and model systems for studying cystic fibrosis. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[21]  K. Chu,et al.  Assessment of ciliary phenotype in primary ciliary dyskinesia by micro-optical coherence tomography. , 2017, JCI insight.

[22]  N. Joo,et al.  Marked increases in mucociliary clearance produced by synergistic secretory agonists or inhibition of the epithelial sodium channel , 2016, Scientific Reports.

[23]  J. Wine,et al.  Airway Gland Structure and Function. , 2015, Physiological reviews.

[24]  Linbo Liu,et al.  A functional anatomic defect of the cystic fibrosis airway. , 2014, American journal of respiratory and critical care medicine.

[25]  E. Hoffman,et al.  Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis , 2014, Science.

[26]  K. Chu,et al.  Characterization of Defects in Ion Transport and Tissue Development in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Knockout Rats , 2014, PloS one.

[27]  Seiko F. Okada,et al.  Mechanosensitive ATP Release Maintains Proper Mucus Hydration of Airways , 2013, Science Signaling.

[28]  Q. Lian,et al.  Contribution of CFTR to Alveolar Fluid Clearance by Lipoxin A4 via PI3K/Akt Pathway in LPS-Induced Acute Lung Injury , 2013, Mediators of inflammation.

[29]  K. Chu,et al.  Method for Quantitative Study of Airway Functional Microanatomy Using Micro-Optical Coherence Tomography , 2013, PloS one.

[30]  C. Schultz,et al.  The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[31]  J. Fahy,et al.  Airway mucus function and dysfunction. , 2010, The New England journal of medicine.

[32]  J. Widdicombe,et al.  CFTR and calcium-activated chloride channels in primary cultures of human airway gland cells of serous or mucous phenotype. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[33]  N. Joo,et al.  Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. , 2010, The Journal of clinical investigation.

[34]  S. Richter,et al.  Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at Birth , 2010, Science Translational Medicine.

[35]  Richard C. Boucher,et al.  Role of mechanical stress in regulating airway surface hydration and mucus clearance rates , 2008, Respiratory Physiology & Neurobiology.

[36]  D. Meyerholz,et al.  Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs , 2008, Science.

[37]  R. Ravazzolo,et al.  Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis. , 2008, The Biochemical journal.

[38]  M. Dolovich,et al.  Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. , 2003, British journal of clinical pharmacology.

[39]  D. Thornton,et al.  Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. , 2002, The Biochemical journal.

[40]  M. Akabas Cystic Fibrosis Transmembrane Conductance Regulator , 2000, The Journal of Biological Chemistry.

[41]  D. Thornton,et al.  Quantitation of mucus glycoproteins blotted onto nitrocellulose membranes. , 1989, Analytical biochemistry.

[42]  M. Sanderson,et al.  Ciliary activity of cultured rabbit tracheal epithelium: beat pattern and metachrony. , 1981, Journal of cell science.

[43]  M. McGuckin,et al.  Detecting, visualising, and quantifying mucins. , 2012, Methods in molecular biology.

[44]  A. Fryer,et al.  Muscarinic receptor antagonists: effects on pulmonary function. , 2012, Handbook of experimental pharmacology.

[45]  G. Downey,et al.  Cystic fibrosis mouse models. , 2007, American journal of respiratory cell and molecular biology.

[46]  S. Rowe,et al.  Cystic fibrosis. , 2005, The New England journal of medicine.

[47]  R. Boucher,et al.  Pathophysiology of gene-targeted mouse models for cystic fibrosis. , 1999, Physiological reviews.